CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency [Phase 4]
Summary
A Phase 4 clinical trial evaluated the effectiveness and safety of Guilu Erxian Oral Liquid for men with oligozoospermia and/or asthenospermia in the context of…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: DongE E Jiao Coporation Limited | Conditions: Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency | Phase 4 | Status: COMPLETED